Skip to main content
Caplight Logo









CapsoVision

CapsoVision

Public
Saratoga, CaliforniaHealthcarehttps://www.capsovision.com

CapsoVision is now publicly traded

The data on this page reflects CapsoVision's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jul 1, 2025

Last Round

Private Placement

Mar 16, 2026

Total Funding Raised

$194.07M

Company Overview

CapsoVision operates in Healthcare and is based in Saratoga, California. Its recorded funding history includes a Series H round in December 2024.

CapsoVision is a medical technology company that develops a video capsule endoscopy system to enhance diagnostic imaging of the gastrointestinal system through a novel panoramic lateral view, allowing for a wireless examination that improves clinical outcomes and patient quality of life.

Sector

Healthcare

Verticals

Digital Health, HealthTech, TMT

AI Layer

Application

CapsoVision Comparables

Compare CapsoVision with similar companies based on industry and business-model similarity.

CapsoVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IntroMedic Co., Ltd.
86%
AnX Robotica
85%
Medtronic
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CapsoVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMar 16, 2026
IPOJul 1, 2025
Series HDec 31, 2024
Series HNov 21, 2019
Series DJan 5, 2018
Series C
Mar 17, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Johnny Wang

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

CapsoVision Investors

Notable investors and investment history

CapsoVision investors
InvestorRounds
ROTH Capital PartnersIPO
The Benchmark CompanyIPO

Recent news

Latest coverage and updates

  • is_developingOct 24, 2026

    CapsoVision, Inc. aims to develop a single ingestible capsule that screens for esophageal, gastric, pancreatic, liver, and colon cancers, with AI tools designed to help identify precancerous lesions.

  • attends_eventOct 13, 2026

    CapsoVision, Inc. presents at the 20th Annual LD Micro Main Event on Oct 21st '26, at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

  • attends_eventSep 3, 2026

    CapsoVision, Inc. announces participation in the 5th Annual ROTH Healthcare Opportunities Conference on Sep 29th '26.

  • has_revenueAug 28, 2026

    CapsoVision, Inc. reports $3.64M in second-quarter revenue on Aug 28th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

CapsoVision Filings

Explore SEC and related filing metadata, where available.

CapsoVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

HeadquartersSaratoga, California
Employee Range86
Year Founded2006
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?